Clin Res Cardiol (2022). https://doi.org/10.1007/s00392-022-02002-5 |
||
Activated rate-response is associated with increased mortality risk in cardiac device carriers with acute heart failure | ||
M. T. Huttelmaier1, S. Münsterer2, C. Morbach3, F. Sahiti2, N. Scholz2, J. Albert2, C. E. Angermann4, G. Ertl4, S. Frantz4, S. Störk2, T. H. Fischer1 | ||
1Med. Klinik und Poliklinik I, Klinische Elektrophysiologie, Universitätsklinikum Würzburg, Würzburg; 2Deutsches Zentrum für Herzinsuffizienz, Universitätsklinikum Würzburg, Würzburg; 3Medizinische Klinik I, Kardiologie, Universitätsklinikum Würzburg, Würzburg; 4Medizinische Klinik und Poliklinik I, Universitätsklinikum Würzburg, Würzburg; | ||
Introduction: In patients with heart failure (HF), chronotropic incompetence is a major factor limiting cardiac output. In patients carrying cardiac implantable electronic devices (CIED), accelerometer-based rate adaption (R-mode) counterbalances chronotropic incompetence during physical activity, but fails to modulate heart rate in situations of high metabolic demand. We hypothesized that an activated R-mode, a reasonable surrogate of chronotropic incompetence, indicates worse prognosis during episodes of acutely decompensated HF (AHF). Methods and Results: The current report is based on 632 patients enrolled in the AHF registry that phenotypes patients admitted for AHF. We compared CIED carriers with activated R-mode stimulation (CIED-R; n=37, 16.2% women) with CIED carriers not in R-mode (CIED-0; n=64, 23.4% women) and patients without CIEDs (no-CIED; n=511, 43.2% women). Mean heart rate at admission was lower in CIED-R vs CIED-0 or no-CIED: 70 bpm vs 80 bpm or 82 bpm; both p<0.001. In-hospital mortality was similar across groups, but 12-month mortality risk was differentially affected by R-mode activation when adjusting for age and sex: CIED-R vs CIED-0, hazard ratio (HR) 2.44, 95%CI 1.25–4.74; CIED-R vs no-CIED, HR 2.61, 95%CI 1.59–4.29. Within CIED-R, mortality risk was similar in patients with pacemakers vs ICDs (HR 1.20, 95%CI 0.49–2.95) and in subgroups with LVEF ≥50% vs <50% (HR 1.10, 95% CI 0.79–1.53). Conclusion: In patients admitted for decompensated heart failure, R-mode stimulation was associated with a markedly higher 12-month mortality risk. Since an activated R-mode is a plausible indicator of chronotropic incompetence, our findings suggest that chronotropic incompetence per se mediates an adverse outcome and may not be adequately treated through accelerometer-based R-mode stimulation in situations of increased metabolic demand. |
||
https://dgk.org/kongress_programme/jt2022/aP847.html |